AGRX

Agile Therapeutics
AGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

45 hedge funds and large institutions have $18.4M invested in Agile Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

40% less capital invested

Capital invested by funds: $30.5M → $18.4M (-$12.2M)

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$177K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.62M
2
+$898K
3
+$190K
4
VF
Virtu Financial
New York
+$102K
5
GCP
GSA Capital Partners
United Kingdom
+$72.2K

Top Sellers

1
-$399K
2
-$215K
3
-$203K
4
NIM
Needham Investment Management
New York
-$189K
5
SGI
Summit Global Investments
Utah
-$121K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$10K
27
$10K
28
$10K
29
$9K
30
$7K
31
$6K
32
$6K
33
$5K
34
$5K
35
$5K
36
$5K
37
$5K
38
$4K
39
$2K
40
$2K
41
$2K
42
$2K
43
$2K
44
$1K
45
$903
46
–
47
–
48
–
49
–
50
–
1
2
3